Galmed Pharmaceuticals Ltd. buy BTIG Research
Start price
08.05.24
/
50%
€0.36
Target price
08.05.25
€58.61
Performance (%)
684.53%
Price
03.09.24
€2.84
Summary
This prediction is currently active. The BUY prediction by BTIG_Research for Galmed Pharmaceuticals Ltd. has seen massive gains of 684.53%. This prediction currently runs until 08.05.25. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Galmed Pharmaceuticals Ltd. | 975.758% | 975.758% |
iShares Core DAX® | -0.372% | 5.236% |
iShares Nasdaq 100 | -1.950% | 1.680% |
iShares Nikkei 225® | -1.690% | 7.286% |
iShares S&P 500 | -0.399% | 2.379% |
Comments by BTIG_Research for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at BTIG Research from $60.00 to $63.00. They now have a "buy" rating on the stock.
Ratings data for GMED provided by MarketBeat
Stopped prediction by BTIG_Research for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.24
28.08.24
28.08.24
€69.28
28.08.25
28.08.25
1093.28%
03.09.24
03.09.24
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.27
16.07.24
16.07.24
€68.81
16.07.25
16.07.25
-15.56%
03.09.24
03.09.24
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.33
29.05.24
29.05.24
€66.36
29.05.25
29.05.25
755.42%
03.09.24
03.09.24
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.30
18.03.24
18.03.24
€55.09
18.03.25
18.03.25
859.46%
03.09.24
03.09.24